Nevro Corporation

Nevro Corporation (Nevro) is an implantable medical device company engaged in developing novel neuromodulation therapies for multiple indications. Neuromodulation is the use of electrical impulses to modulate the activity in the central, peripheral or autonomic nervous systems and treats severe chronic illness due to persistent pain, spasticity, movement disorders, epilepsy, ischemia, cardiac, bowel and bladder dysfunction, among other conditions. The company is involved in the development of an implantable device for the treatment of chronic pain. The company is headquartered in Palo Alto, the US.

Street: 
411 Acacia Avenue
City: 
Palo Alto
Postcode: 
94306
Federal State : 
United States
WebSite: 
www.nevrocorp.com
Fax: 
1-650-2519415

Company Index Score

Current Index Score Historical Index Score
  • Nevro Corporation currently scores 50 % in the index.
  • Nevro Corporation is currently ranked equal 15 out of a total of 35419 included in the NS Company Index. This is the top 0.042 % of all companies.
  • Nevro Corporation is currently ranked 3 out of 8430 companies. This is in the top 0.036 % percent of Healthcare companies ranked in the index.
  • User perception of the company stands at 0 % percent. This differs 50 % percent over the score attributed to the company by other scoring factors.

Latest tweets